ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Kidney Diseases

Diabetes trials near Nashville, TN, USA:

Teplizumab in Pediatric Stage 2 Type 1 Diabetes (PETITE-T1D)

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...

Enrolling
Diabetes Mellitus, Type 1
Biological: teplizumab

Phase 4

Provention Bio, a Sanofi Company

Nashville, Tennessee, United States and 9 other locations

The central hypothesis is that inflammation mediators are biomarkers of both systemic diabetes and Diabetic Retinopathy (DR) progre...

Active, not recruiting
Diabetic Retinopathy
Other: Aqueous PGE2 and inflammatory cytokines measurements
Drug: Ketorolac 0.45% ophthalmic solution

Phase 1

Stephen J. Kim, MD

Nashville, Tennessee, United States

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)
Procedure: Sham Comparator

Phase 3

Prokidney

Nashville, Tennessee, United States and 45 other locations

double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Nonalcoholic Steatohepatitis (NASH)
Drug: Placebo
Drug: HTD1801

Phase 2

HighTide Therapeutics

Clarksville, Tennessee, United States and 54 other locations

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Nashville, Tennessee, United States and 58 other locations

control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...

Enrolling
Diabetes Mellitus, Type 1
Drug: Ritlecitinib
Drug: Abrocitinib 200 MG Oral Tablet

Phase 2

National Institutes of Health (NIH)
National Institutes of Health (NIH)

Nashville, Tennessee, United States and 17 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Nashville, Tennessee, United States and 175 other locations

the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, ...

Enrolling
Diabetic Foot Ulcer
Device: COMS One device
Device: Sham device
Piomic Medical

Nashville, Tennessee, United States and 16 other locations

Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Ma...

Active, not recruiting
Diabetic Retinopathy
Drug: Intravitreal Ranibizumab 0.5 mg Injection
Drug: PDS Implant Pre-Filled with 100 mg/mL Ranibizumab

Phase 3

Roche
Roche

Nashville, Tennessee, United States and 60 other locations

Recently updated

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Part...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Nashville, Tennessee, United States and 468 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems